| 5 Einträge |
| Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | |
| Autoren | Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SK, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M |
| Erscheinungsdaten | The Lancet. Oncology. 2016 Feb 10. pii: S1470-2045(15)00551-3. doi: 10.1016/S1470-2045(15)00551-3 |
| Publikations ID | PMID: 26874901 |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. | |
| Autoren | Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| Erscheinungsdaten | The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| Publikations ID | PMID: 29146401 |
| JunB is a key regulator of multiple myeloma bone marrow angiogenesis. | |
| Autoren | Fan F, Malvestiti S, Vallet S, Lind J, Garcia-Manteiga JM, Morelli E, Jiang Q, Seckinger A, Hose D, Goldschmidt H, Stadlbauer A, Sun C, Mei H, Pecherstorfer M, Bakiri L, Wagner EF, Tonon G, Sattler M, Hu Y, Tassone P, Jaeger D, Podar K |
| Erscheinungsdaten | Leukemia. 2021 May 18. doi: 10.1038/s41375-021-01271-9. pii: 10.1038/s41375-021-01271-9 |
| Publikations ID | PMID: 34007044 |
| Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis. | |
| Autoren | Fan F, Malvestiti S, Vallet S, Lind J, Garcia-Manteiga JM, Morelli E, Jiang Q, Seckinger A, Hose D, Goldschmidt H, Stadlbauer A, Sun C, Mei H, Pecherstorfer M, Bakiri L, Wagner EF, Tonon G, Sattler M, Hu Y, Tassone P, Jaeger D, Podar K |
| Erscheinungsdaten | Leukemia. 2021 Sep 6. doi: 10.1038/s41375-021-01367-2. pii: 10.1038/s41375-021-01367-2 |
| Publikations ID | PMID: 34489554 |
| STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models. | |
| Autoren | Marino F, Orecchia V, Regis G, Musteanu M, Tassone B, Jon C, Forni M, Calautti E, Chiarle R, Eferl R, Poli V |
| Erscheinungsdaten | American journal of cancer research. 2014 Sep 6. pmc: PMC4163613 |
| Publikations ID | PMID: 25232490 |